COVID-19 Clinical Trials

RBHS COVID-19 Clinical Trials

RBHS is actively engaged in scientific discovery surrounding COVID-19. 

Below are RBHS COVID-19 clinical trials.

 

RBHS Active COVID-19 Clinical Trials

Study TitlePI
A Multicenter, Adaptive, Randomized Controlled Platform Trial of the Safety and Efficacy of Antithrombotic Strategies in Hospitalized Adults with COVID-19Yonatan Greenstein
A randomized controlled trial to evaluate the outcomes with Aggrenox in patients with SARS-CoV-2 infectionAmit Singla
A Phase 3, Randomized, Stratified, Observer-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1273 SARS-CoV-2 Vaccine in Adults Aged 18 Years and OlderShobha Swaminathan
C298-020; A Randomized, Double-Blind, Placebo Controlled Study to Evaluate Safetyand Efficacy of DUR-928 in Subjects Infected with SARS-CoV-2 with Acute or Chronic Liver or Kidney DiseaseNikolaos Pyrsopoulos
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Ruxolitinib in Participants With COVID-19–Associated ARDS Who Require Mechanical Ventilation (RUXCOVID-DEVENT)Amee Patrawalla
A Phase 2 double-blind placebo-controlled study investigating the safety and efficacy of EDP1815 in the treatment of patients hospitalized with SARS-CoV-2 InfectionRey Panettieri
Keith Guevarra
Treatment of Patients Hospitalized for Covid-19 Infection and Pulmonary Distress with ZanubrutinibTilly Varughese
A5395 A Randomized, Double Blind, Placebo Controlled Trial to Evaluate the Efficacy of Hydroxychloroquine and Azithromycin to Prevent Hospitalization or Death in Persons with COVID-19Michelle Dalla Piazza
Investigational Covid-19 Convalescent Plasma Infusion for severely or life-threateningly ill Covid-19 PatientsMarc Klapholz
Emergency Use of COVID-19 Covalescent Plasma in a Patient with Coronavirus Disease (COVID-19)Marc Klapholz
Tilly Varughese
A Phase 2 double-blind placebo-controlled study investigating the safety and efficacy of EDP1815 in the treatment of patients hospitalized with SARS-CoV-2 InfectionRey Panettieri
Clinical Features of COVID-19 Disease in Critically Ill Patients in the US: A Multicenter StudyJared Radbel
Hemolung RAS Emergency Use Authorizations for COVID-19Sabiha Hussain
Jared Radbel
A Randomized, Double-blind, Vehicle-Controlled, Multicenter, Parallel-Group Study of APL-9 in Mild to Moderate Acute Respiratory Distress Syndrome Due to COVID-19Sabiha Hussain
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Assess the Efficacy and Safety of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults Aged 18 Years and OlderJeffrey Carson
Influenza and Other Emerging Respiratory Pathogens Surveillance RegistryLawrence Kleinman
Influenza Vaccine Effectiveness for Preventing Laboratory-Confirmed Severe Influenza-Associated Illness and Understanding Coronavirus Disease 2019 (Overcoming COVID-19) in US ChildrenLawrence Kleinman
The Pediatric COVID-19 Experience in Central New JerseyLawrence Kleinman
Seroprevalence of infection with SARS-CoV-2 VirusMarila Gennaro
Fecal Study on COVID-19 PatientsVinod Rustgi